Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Citigroup To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Wednesday

Published 14/02/2024, 12:49
© Reuters. Citigroup To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Wednesday

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Keybanc raised the price target for CrowdStrike Holdings, Inc. (NASDAQ: CRWD) from $318 to $375. Keybanc analyst Eric Heath maintained an Overweight rating. CrowdStrike shares rose 0.4% to close at $322.44 on Tuesday. See how other analysts view this stock.
  • Piper Sandler boosted Shopify Inc. (NYSE: SHOP) price target from $56 to $63. Piper Sandler analyst Clarke Jeffries maintained an Underweight rating. Shopify shares fell 13.4% to close at $77.18 on Tuesday. See how other analysts view this stock.
  • Needham boosted the price target for SS&C Technologies Holdings, Inc. (NASDAQ: SSNC) from $62 to $70. Needham analyst Mayank Tandon maintained a Buy rating. SS&C Technologies shares fell 1.8% to close at $60.15 on Tuesday. See how other analysts view this stock.
  • JP Morgan raised Bruker Corporation (NASDAQ: BRKR) price target from $60 to $90. JP Morgan analyst Tycho Peterson upgraded the stock from Neutral to Overweight. Bruker shares jumped 8.8% to close at $76.79 on Tuesday. See how other analysts view this stock.
  • HSBC increased the price target for HP Inc. (NYSE: HPQ) from $30 to $33. HSBC analyst Stephen Bersey upgraded the stock from Hold to Buy. HP shares fell 1.9% to close at $28.14 on Tuesday. See how other analysts view this stock.
  • Piper Sandler raised the price target for Citigroup Inc. (NYSE: C) from $56 to $63. Piper Sandler analyst Scott Siefers upgraded the stock from Neutral to Overweight. Citigroup shares fell 2.2% to close at $52.76 on Tuesday. See how other analysts view this stock.
  • HC Wainwright & Co. increased KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) price target from $16 to $24. HC Wainwright & Co. analyst Andrew Fein maintained a Buy rating. KalVista Pharmaceuticals shares fell 7.4% to close at $14.85 on Tuesday. See how other analysts view this stock.
  • Wedbush cut Denny's Corporation (NASDAQ: DENN) price target from $11 to $10.5. Wedbush analyst Nick Setyan maintained a Neutral rating. Denny's shares fell 4.2% to close at $9.91 on Tuesday. See how other analysts view this stock.
  • Needham cut Biogen Inc. (NASDAQ: BIIB) price target from $305 to $300. Needham analyst Ami Fadia maintained a Buy rating. Biogen shares fell 7.4% to close at $226.65 on Tuesday. See how other analysts view this stock.
  • Keybanc boosted MongoDB, Inc. (NASDAQ: MDB) price target from $500 to $543. Keybanc analyst Eric Heath maintained an Overweight rating. MongoDB shares fell 3.3% to close at $472.13 on Tuesday. See how other analysts view this stock.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Check This Out: Kraft Heinz, Lyft And 3 Stocks To Watch Heading Into Wednesday

Latest Ratings for C

Mar 2022Credit SuisseMaintainsOutperform
Mar 2022JefferiesDowngradesBuyHold
Mar 2022BMO CapitalMaintainsOutperform

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.